documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

11 rows where agency_id = "FDA" and docket_id = "FDA-2006-E-0197" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), last_modified (date)

posted_year 3

document_type 2

agency_id 1

  • FDA · 11 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2006-E-0197-0011 FDA Patent Extension Application for SPRYCEL (dasatinib), U.S. Patent No. 6,596,746 FDA-2006-E-0197 Letter from U.S. Patent and Trademark Office to Bristol-Myers Squibb Co. Other Letter(s) 2008-10-29T04:00:00Z 2008 10 2008-10-29T04:00:00Z   2025-12-19T00:55:02Z   0 0 09000064807736b5
FDA-2006-E-0197-0010 FDA Patent Extension Application for SPRYCEL (dasatinib), U.S. Patent No. 6,596,746 FDA-2006-E-0197 Notice of Final Determination from U.S. Patent and Trademark Office to Bristol-Myers Squibb Company Other Letter(s) 2008-10-29T04:00:00Z 2008 10 2008-10-29T04:00:00Z   2025-12-19T00:50:34Z   0 0 090000648068ce0e
FDA-2006-E-0197-0008 FDA Patent Extension Application for SPRYCEL (dasatinib), U.S. Patent No. 6,596,746 FDA-2006-E-0197 Application for Patent Term Extension from Bristol-Myers Squibb Company Other Application 2008-10-29T04:00:00Z 2008 10 2008-10-29T04:00:00Z   2025-12-19T00:46:37Z   0 0 0900006480450ef2
FDA-2006-E-0197-0009 FDA Patent Extension Application for SPRYCEL (dasatinib), U.S. Patent No. 6,596,746 FDA-2006-E-0197 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2008-10-29T04:00:00Z 2008 10 2008-10-29T04:00:00Z   2025-12-19T00:48:12Z   0 0 090000648068cdf4
FDA-2006-E-0197-0007 FDA Patent Extension Application for SPRYCEL (dasatinib), U.S. Patent No. 6,596,746 FDA-2006-E-0197 Determination of Regulatory Review Periods for Purposes of Patent Extension; SPRYCEL--New Drug Applications 2 1-986 and 22-072 Notice General Notice 2007-05-25T04:00:00Z 2007 5 2007-05-25T04:00:00Z   2025-12-19T00:33:26Z E7-10089 0 0 0900006480450efc
FDA-2006-E-0197-0006 FDA Patent Extension Application for SPRYCEL (dasatinib), U.S. Patent No. 6,596,746 FDA-2006-E-0197 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2007-05-17T04:00:00Z 2007 5     2025-12-19T00:29:59Z   0 0 0900006480450efb
FDA-2006-E-0197-0005 FDA Patent Extension Application for SPRYCEL (dasatinib), U.S. Patent No. 6,596,746 FDA-2006-E-0197 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2007-03-06T05:00:00Z 2007 3     2025-12-19T00:14:46Z   0 0 0900006480450efa
FDA-2006-E-0197-0004 FDA Patent Extension Application for SPRYCEL (dasatinib), U.S. Patent No. 6,596,746 FDA-2006-E-0197 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2007-01-26T05:00:00Z 2007 1     2025-12-19T00:08:24Z   0 0 0900006480450ef9
FDA-2006-E-0197-0003 FDA Patent Extension Application for SPRYCEL (dasatinib), U.S. Patent No. 6,596,746 FDA-2006-E-0197 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2007-01-26T05:00:00Z 2007 1     2025-12-19T00:06:08Z   0 0 0900006480450ef8
FDA-2006-E-0197-0001 FDA Patent Extension Application for SPRYCEL (dasatinib), U.S. Patent No. 6,596,746 FDA-2006-E-0197 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2006-12-15T05:00:00Z 2006 12     2025-12-19T00:01:54Z   0 0 0900006480450eec
FDA-2006-E-0197-0002 FDA Patent Extension Application for SPRYCEL (dasatinib), U.S. Patent No. 6,596,746 FDA-2006-E-0197 Notice of Informalities from U.S. Patent and Trademark Office to Bristol-Myers Squibb Company Other Letter(s) 2006-12-15T05:00:00Z 2006 12     2025-12-19T00:04:01Z   0 0 0900006480450ef7

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);